InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,166.40
(
0.51%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,190.22
(
0.28%
)

Replies to post #1153 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1153 on Enanta Pharmaceuticals Inc (ENTA)

NY1972

10/26/15 9:28 AM

#1154 RE: DewDiligence #1153

Out of 27 cases mentioned in FDA PR, how many were GT1, US patients?

DewDiligence

10/28/15 8:42 AM

#1162 RE: DewDiligence #1153

ESRX CC: No change expected in V-Pak utilization due to revised FDA label.